Updated COVID-19 vaccines are now recommended for everyone 5 years
Créditos: Comité científico Covid
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
Question Among individuals who had symptomatic SARS-CoV-2 infection in 2020 and 2021, what proportion experienced common self-reported Long COVID symptom clusters 3 months after initial infection? Findings This observational analysis involved bayesian meta-regression and pooling of 54 studies and 2 medical record databases with data for 1.2 million individuals (from 22 countries) […]
2022 U.S. Map & Case Count
27,022Total confirmed monkeypox/orthopoxvirus cases *One Florida case is listed here but included in the United Kingdom case counts because the individual was tested while in the UK. https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html Créditos: Comité científico Covid
How Accurate Are Home Antigen Tests for Omicron?
Unsupervised SARS-CoV-2 rapid antigen testing with three commercial kits had 70% to 81% sensitivity during the period when Omicron emerged and became predominant in the Netherlands. Rapid antigen testing for COVID-19 has largely replaced RT-PCR testing in the ambulatory setting, but accuracy data are limited. Dutch investigators performed a prospective […]
Una cepa de Salmonella Newport multirresistente en México
Puntos clave Algunos viajeros que han pasado tiempo en México se han infectado con Salmonella Newport multirresistente (MDR, por sus siglas en inglés). La Salmonella MDR ha desarrollado la capacidad de vencer a los medicamentos diseñados para eliminarla. Las infecciones por Salmonella MDR pueden ser difíciles de tratar. Los médicos deben seguir las directrices de los CDC […]
FDA releases important information about risk of COVID-19 due to certain variants not neutralized by Evusheld
FDA added important information to the authorized Fact Sheets for Evusheld (tixagevimab co-packaged with cilgavimab) to inform health care providers and individuals receiving Evusheld of the increased risk for developing COVID-19 when exposed to variants of SARS-CoV-2 that are not neutralized by Evusheld. Detailed neutralization data can be found in […]
En decremento, contagios y muertes a nivel mundial
“No hemos llegado al final de la pandemia: aún estamos en el túnel y hay muchos obstáculos que pueden hacernos tropezar: brechas de vacunación, bajos índices de pruebas y secuenciación, así como falta de acceso a antivirales”, advirtió el lunes 26 de septiembre el director general de la Organización Mundial […]
Defeating meningitis by 2030
Despite significant progress over the last few decades, meningitis remains a much-feared disease worldwide with a high case fatality rate and a propensity to cause epidemics that present a major challenge for health systems, economies and society. Meningitis caused an estimated 250 000 deaths in 2019, leaving one in five […]
COVID-19 Integrated County View
This site provides an integrated, county view of key data for monitoring the COVID-19 pandemic in the United States. It allows for the exploration of standardized data across the country.§ The footnotes describe each data source and the methods used for calculating the metrics. For the most complete and up-to-date data […]
Preventive Medication for COVID-19 Infection
Tixagevimab-cilgavimab is a combination medication to help prevent COVID-19 infection. Tixagevimab-cilgavimab (Evusheld) consists of 2 long-acting monoclonal antibodies that bind to the spike protein of the virus that causes COVID-19 to prevent it from infecting human cells. When Can Tixagevimab-Cilgavimab Be Given? Tixagevimab-cilgavimab is not a treatment for COVID-19 and […]